An experimental drug developed by a US-based team of researchers led by a Greek scientist has been shown to dramatically improve survival rates for the deadly Ebola haemorrhagic fever.
The antibody cocktail called REGN-EB3 was developed by Regeneron Pharmaceuticals where Dr Christos Kyratsous is vice president of research, infectious diseases and viral vector technologies.
Currently there is no West Nile fever in Bulgaria. This was reported by BNT, quoted by Dr. Magdalena Baymakova of the Military Medical Academy.
According to the European Center for Infectious Disease Control, there are currently 33 people infected with the West Nile fever. They are in Greece, France, Hungary and Italy.
The Athens Medical Association (ISA) has expressed concern about the spread of West Nile virus and is urging the public to take all necessary precautions.
In a statement, it noted that there were 316 reported cases of the mosquito-borne infection last year, and that 50 of them were fatal. Most of the deaths, it said, were recorded in Attica.
The situation had become critical when the virus had spread to the city of Goma, home to two million citizens. This city is situated on the border with Uganda, and Congo officials claim that a priest who used several false names brought the disease into the city.